BACTEC™ FXI Culture System

The BD BACTEC™ FXI Culture System is a next-generation, fully automated blood culture system designed for the detection of bloodstream infections, including sepsis-causing pathogens. It builds on BD’s established BACTEC platform and is engineered to improve speed, consistency, and diagnostic accuracy in microbiology laboratories. The system supports high-throughput workflows and incorporates advanced automation and data-driven features to help laboratories detect positive blood cultures earlier and support timely clinical decision-making.

[Available in Republic Of Ireland and Northern Ireland]

Description

Features

Fully automated blood culture processing (loading, incubation, detection, and alerting)
Advanced fluorescence-based detection technology for rapid organism identification
Automated gravimetric measurement of blood volume in each vial for quality control
High-throughput modular design supporting large laboratory workloads (up to ~960 vials per system configuration)
Vial-activated workflow to reduce manual handling and improve efficiency
Integrated barcode scanning and LCD touchscreen interface per module
Real-time quality and operational data dashboards (via BD Synapsys™ Informatics integration)
Intelligent data management for tracking turnaround time, contamination rates, and results communication
Scalable architecture adaptable to different laboratory sizes and configurations
Designed for seamless integration into antimicrobial stewardship and lab automation workflows

Benefits

Enables faster detection of bloodstream pathogens (around ~3 hours faster than previous generation systems)
Supports earlier initiation of targeted antimicrobial therapy in sepsis and infection cases
Improves diagnostic accuracy through standardized blood volume measurement per sample
Reduces manual workload and hands-on time for laboratory staff
Enhances laboratory efficiency through automation and high-throughput capacity
Improves consistency and quality of blood culture results
Supports better clinical decision-making and antimicrobial stewardship
Helps laboratories manage increasing testing demand with scalable system design
May contribute to improved patient outcomes through faster diagnosis and treatment initiation